Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)
Status:
Withdrawn
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Assess the effect of nepicastat in the treatment of in Post Traumatic Stress Disorder (PTSD)
in conflict or combat zone experienced veterans, in comparison to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Michael Debakey Veterans Affairs Medical Center Michael E. DeBakey VA Medical Center
Collaborators:
Acorda Therapeutics Biotie Therapies Inc. Lori Davis, MD Tuscaloosa VA Medical Center Ralph H. Johnson VA Medical Center Tuscaloosa Veterans Affairs Medical Center